Technovers GmbH, since its establishment in 2017 as a German company, has focused on research, development, and innovation in biotechnology and life sciences, supporting the design and development of next-generation products through advanced scientific expertise. We specialize in the discovery, optimization, and scale-up of bioactive compounds, peptides, plant extracts, natural ingredients, and other high-value substances for pharmaceutical, nutraceutical, cosmetic, and biotechnology applications.

By combining laboratory research with advanced artificial intelligence (AI) tools, we accelerate product design, predictive modeling, data analysis, and process optimization, enabling faster innovation and more efficient development pipelines. Our multidisciplinary R&D capabilities at Technovers GmbH support proof-of-concept studies, formulation development, technology transfer, pilot-scale production, and the translation of scientific know-how into commercially viable products.

Working closely with biotechnology companies, research institutes, universities, and industrial partners in Germany and worldwide, Technovers GmbH provides contract research, analytical services, and manufacturing support while maintaining high quality and regulatory standards. We also have experience in the development of pharmaceutical and veterinary products, complementing our broader focus on innovative, science-driven solutions and sustainable product development.

Our experienced bioinformatics specialists also provide research services for the analysis of transcriptomics and next-generation sequencing (NGS) data.